Biomarkers for predicting future metastasis of human gastrointestinal tumors.
The recent advances in surgery and radiation therapy have significantly improved the prognosis of patients with primary cancer, and the major challenge of cancer treatment now is metastatic disease development. The 5-year survival rate of cancer patients who have distant metastasis at diagnosis is extremely low, suggesting that prediction and early detection of metastasis would definitely improve their prognosis because suitable patient therapeutic management and treatment strategy can be provided. Cancer cells from a primary site give rise to a metastatic tumor via a number of steps which require the involvement and altered expression of many regulators. These regulators may serve as biomarkers for predicting metastasis. Over the past few years, numerous regulators have been found correlating with metastasis. In this review, we summarize the findings of a number of potential biomarkers that are involved in cadherin-catenin interaction, integrin signaling, PI3K/Akt/mTOR signaling and cancer stem cell identification in gastrointestinal cancers. We will also discuss how certain biomarkers are associated with the tumor microenvironment that favors cancer metastasis.
Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China, luing@hku.hk.
Lui
L
Ng
Ronnie Tung Ping
RT
Poon
Roberta
R
Pang
D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D055088:Early Detection of Cancer / Q000379:methods; D005770:Gastrointestinal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D009362:Neoplasm Metastasis; D059016:Tumor Microenvironment / Q000502:physiology
D014408:Biomarkers, Tumor